Trademark: 90631529
Status Date
Wednesday, February 28, 2024
Filing Date
Thursday, April 8, 2021
Published for Opposition
Tuesday, January 4, 2022
5 Therapeutic pharmaceuticals and agents for the treatment of disease, namely, cancer; pharmaceutical preparations and agents for the treatment of cancer; pharmaceutical preparations and agents used to inhibit kinase for use in the treatment of cancer
Feb 29, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 28, 2024
Sou Extension 4 Granted
Feb 28, 2024
Sou Extension 4 Filed
Feb 28, 2024
Sou Teas Extension Received
Aug 31, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 29, 2023
Sou Extension 3 Granted
Aug 29, 2023
Sou Extension 3 Filed
Aug 29, 2023
Sou Teas Extension Received
Feb 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 24, 2023
Sou Extension 2 Granted
Feb 24, 2023
Sou Extension 2 Filed
Feb 24, 2023
Sou Teas Extension Received
Sep 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 30, 2022
Sou Extension 1 Granted
Aug 30, 2022
Sou Extension 1 Filed
Aug 30, 2022
Sou Teas Extension Received
Mar 1, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 4, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 4, 2022
Published For Opposition
Dec 15, 2021
Notification Of Notice Of Publication E-Mailed
Dec 1, 2021
Assigned To Lie
Nov 30, 2021
Approved For Pub - Principal Register
Nov 29, 2021
Assigned To Examiner
May 6, 2021
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24